In this uncut reflection I talk about the long-recognised disconnect between symptoms and gut inflammation, and why treat-to-target requires us to measure both.
I outline our Edinburgh work using longitudinal faecal calprotectin and CRP to model inflammatory behaviour over time; at service level and for the individual patient.
This is the analytics engine behind Sentinel, our AI-driven dynamic clinical decision support tool.
We’re preparing a pilot now, with first patient in January.
